Pharmacology of cyanate. I. General effects on experimental animals
Cerami, A.; Allen, T.A.; Graziano, J.H.; DeFuria, F.G.; Manning, J.M.; Gillette, P.N.
Journal of Pharmacology and Experimental Therapeutics 185(3): 653-666
1973
ISSN/ISBN: 0022-3565 PMID: 4197279 Document Number: 5613
The development of cyanate as an antisickling drug in the treatment of sickle cell disease necessitated an investigation of its effect on experimental animals. The LD,," for a single i.p. injection of NaNCO and KNCO was 260 and 320 mg/kg, respectively. The i.p. injection of KNCO (32 mg/kg) to mice once daily (five times a week) for a five-month period had no adverse effects. In addition, sodium cyanate was administered orally to dogs (100 mg/kg of NaNCO) and monkeys (100 mg/kg of NaNCO) for a 15-month period without any apparent ill effects being observed. In fact, the only measurable difference between the control animals and the animals receiving cyanate was an increase in the oxygen affinity of the blood of all the species receiving cyanate. Although this change in the 1350 of the blood is quite dramatic, no physiological or pathological sequelae have been observed in animals receiving cyanate. The specificity of the cyanate for the NH,-terminal valine of hemoglobin is quite striking. Continuous cyanate administration leads to an accumulation of -1 carbamyl group per hemoglobin tetramer with no measurable carbamylation of the E-amino groups of lysine residues of hemoglobin. The injection of 10 μcool of "C-cyanate to a mouse produced the following distribution of radioactivity: 72% broken down to CO", 7% in the urine, 7.5% as a specific carbamylation of the NIL-terminal valine of hemoglobin, 3.3% in bones, 2.1% in muscle, and less than 3% in all the other organs. The chronic administration of cyanate leads to an accumulation of carbamyl groups on the hemoglobin and in other organs although the number of carbamyl groups in all the various compartments eventually plateaus after different periods of time. The similarity in structure and reactivity of CO, and cyanate probably accounts for the specificity of cyanate for the NH2-terminal valine of hemoglobin. It is thus possible to achieve -1 carbamyl group per hemoglobin tetramer without seriously affecting the well-being of the species studied.
Document emailed within 1 workday
